Reuters: Common asthma drug cuts COVID-19 hospitalization risk, recovery time – Oxford study 10 February 2021 Health and Wellbeing The 28-day study of 146 patients suggested that inhaled budesonide reduced the risk of urgent care or hospitalization by 90% when compared Read More
US Congress hearing: COVID-19 – ‘Exactly What You’d Expect If You’d Gone Through Gain-Of-Function’ – Forbes Breaking News 4 July 2021
